Jay Venkatesan, Director, 10% Owner at ALPINE IMMUNE SCIENCES, INC. (ALPN), bought 381,750 shares at $5.37 ($2.0M) on 2019-01-18, disclosed to the SEC on 2019-01-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.37 | 190,875 | $1.0M | 50.0% |
| 2 | $5.37 | 190,875 | $1.0M | 50.0% |
| Total | $5.37 avg | 381,750 | $2.0M | 100% |
| Filing → |
| ANGN | BUY | 2022-05-25 | $101K | — | Filing → |
| ANGN | BUY | 2021-12-29 | $1.5M | — | Filing → |
| ANGN | BUY | 2021-12-22 | $9K | — | Filing → |